Search filters

List of works by Hartmut J Ehrlich

A Cell Culture-Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals ⬇️

scientific article published on January 19, 2012

A Vero Cell–Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies ⬇️

scientific article published on November 16, 2011

A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.

scientific article

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

scientific article

A close look at human IgG sialylation and subclass distribution after lectin fractionation

scientific article

A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory

scientific article published on July 28, 2012

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans

scientific article published on June 2011

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

scientific article

Activated protein C: more effective than nonactivated protein C?

scientific article published on 01 May 2003

Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1)

scientific article published on 01 July 2011

Anti-amyloidogenic activity of IgGs contained in normal plasma

scientific article

Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.

scientific article published on June 2012

Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming.

scientific article

Clinical development of a Vero cell culture-derived seasonal influenza vaccine ⬇️

scientific article published on December 13, 2011

Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine

scientific article published on 7 May 2010

Comparison of immunogenicity and safety between two paediatric TBE vaccines.

scientific article published on 28 April 2010

Comparison of plasma-derived and recombinant von Willebrand factor by atomic force microscopy

scientific article published on 29 June 2010

Developing cell culture-derived pandemic vaccines.

scientific article

Efficacy and physiological effects of human butyrylcholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guinea-pig

scientific article published on 20 February 2010

Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency

scientific article published on 17 May 2006

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial ⬇️

scientific article published on February 15, 2011

Ethanol dependence of alpha 1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases

scientific article published on 19 November 2007

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.

scientific article

Glycoproteomic characterization of butyrylcholinesterase from human plasma

scientific article

Group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posology

scientific article published on 13 July 2005

H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model

scientific article (publication date: 2011)

History of TBE vaccines

scientific article published in April 2003

Human Anti-Macrophage Migration Inhibitory Factor Antibodies Inhibit Growth of Human Prostate Cancer Cells In Vitro and In Vivo ⬇️

scientific article published on April 25, 2013

Human anti-Aβ IgGs target conformational epitopes on synthetic dimer assemblies and the AD brain-derived peptide

scientific article

Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice

scientific article

Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia A

article

Neutralization of macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the β-sheet structure of MIF.

scientific article

Only activated protein C treatment and not protein C has demonstrated an improvement in survival in severe sepsis

scientific article published on 01 February 2004

Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects

scientific article published on 20 December 2016

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

scientific article

Preclinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitability

scientific article published on 14 July 2010

Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza ⬇️

scientific article published on October 7, 2011

Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.

scientific article published on 16 August 2011

RNA sequencing analysis of activated macrophages treated with the anti-HIV ABX464 in intestinal inflammation

scientific article published on 17 October 2017

Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects

scientific article published on 31 October 2016

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity ⬇️

scientific article published on December 12, 2003

Re: Tick-borne encephalitis (TBE) trends in epidemiology and current and future management

scientific article published on 21 February 2011

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.

scientific article published on 10 May 2013

Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients

scientific article

Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.

scientific article

Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial

scientific article published on 12 October 2011

Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine

scientific article

Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study

scientific article

Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study

article

Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions.

scientific article

Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years

scientific article published on August 2009

Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants ⬇️

scientific article published on May 11, 2013

Small Peptides Blocking Inhibition of Factor Xa and Tissue Factor-Factor VIIa by Tissue Factor Pathway Inhibitor (TFPI)

scientific article

Structure and function of a recombinant von Willebrand factor drug candidate

scientific article published on 15 July 2010

The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages

scientific article

The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants

scientific article published on 23 January 2009

Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance

scientific article published on January 2003

Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity ⬇️

scientific article (publication date: 24 January 2011)

Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development ⬇️

scientific article published on April 1, 2013

Paulina is supported by:

About Paulina

Help